Rockefeller Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
+26,773
| New | +$220K | ﹤0.01% | 1703 |
|
|
2025
Q1 | – | Sell |
-27,108
| Closed | -$210K | – | 1727 |
|
|
2024
Q4 | $210K | Sell |
27,108
-13,864
| -34% | -$107K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $430K | Buy |
40,972
+17
| +0% | +$178 | ﹤0.01% | 1469 |
|
|
2024
Q2 | $479K | Sell |
40,955
-16
| -0% | -$187 | ﹤0.01% | 1443 |
|
|
2024
Q1 | $863K | Sell |
40,971
-81
| -0.2% | -$1.71K | ﹤0.01% | 1311 |
|
|
2023
Q4 | $737K | Buy |
41,052
+155
| +0.4% | +$2.78K | ﹤0.01% | 1243 |
|
|
2023
Q3 | $673K | Hold |
40,897
| – | – | ﹤0.01% | 1218 |
|
|
2023
Q2 | $818K | Hold |
40,897
| – | – | ﹤0.01% | 1167 |
|
|
2023
Q1 | $773K | Buy |
40,897
+40,662
| +17,303% | +$769K | ﹤0.01% | 1171 |
|
|
2022
Q4 | $5K | Sell |
235
-300
| -56% | -$6.38K | ﹤0.01% | 3340 |
|
|
2022
Q3 | $14K | Sell |
535
-450
| -46% | -$11.8K | ﹤0.01% | 2942 |
|
|
2022
Q2 | $24K | Buy |
985
+250
| +34% | +$6.09K | ﹤0.01% | 2643 |
|
|
2022
Q1 | $24K | Hold |
735
| – | – | ﹤0.01% | 2644 |
|
|
2021
Q4 | $24K | Hold |
735
| – | – | ﹤0.01% | 2563 |
|
|
2021
Q3 | $30K | Hold |
735
| – | – | ﹤0.01% | 2399 |
|
|
2021
Q2 | $28K | Hold |
735
| – | – | ﹤0.01% | 2332 |
|
|
2021
Q1 | $25K | Buy |
735
+235
| +47% | +$7.99K | ﹤0.01% | 2188 |
|
|
2020
Q4 | $22K | Hold |
500
| – | – | ﹤0.01% | 1970 |
|
|
2020
Q3 | $13K | Buy |
+500
| New | +$13K | ﹤0.01% | 1943 |
|
|
2019
Q2 | – | Sell |
-100
| Closed | -$6K | – | 1911 |
|
|
2019
Q1 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 1601 |
|